PIERIS PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
40 Contracts & Agreements
- Offer Letter, dated August 19, 2019, by and between Kathleen Goin and Palvella Therapeutics, Inc (Filed With SEC on August 9, 2024)
- Offer Letter, dated July 27, 2020, by and between Jeffrey Martini and Palvella Therapeutics, Inc (Filed With SEC on August 9, 2024)
- Offer Letter, dated August 31, 2018, by and between Kathleen A. McGowan and Palvella Therapeutics, Inc (Filed With SEC on August 9, 2024)
- Form of Lock-Up Agreement (Filed With SEC on July 24, 2024)
- Form of Pieris Support Agreement (Filed With SEC on July 24, 2024)
- Form of Contingent Value Rights Agreement (Filed With SEC on July 24, 2024)
- Form of Palvella Support Agreement (Filed With SEC on July 24, 2024)
- Non-Exclusive Anticalin Platform Technology License Agreement by and among the Registrant, Pieris Pharmaceuticals GmbH and Seagen, Inc., dated February 8, 2018 (Filed With SEC on May 15, 2024)
- License and Collaboration Agreement by and among the Registrant, Pieris GmbH and Seagen, Inc., dated February 8, 2018 (Filed With SEC on May 15, 2024)
- Retention Letter by and between Pieris GmbH and Shane Olwill, Ph.D., dated February 22, 2024 (Filed With SEC on March 29, 2024)
- Amendments to the Employment Agreement by and between Pieris GmbH and Shane Olwill, Ph.D., dated between 2012-2021 (Filed With SEC on March 29, 2024)
- Employment Agreement by and between Pieris GmbH and Shane Olwill, Ph.D. dated May 9, 2011 (Filed With SEC on March 29, 2024)
- Amendment No. 1, dated December 11, 2023, to Consulting Agreement by and between the Registrant and Ahmed Mousa (Filed With SEC on March 29, 2024)
- Amendment No. 4 to Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermgen GmbH, dated December 15, 2023 (English translation) (Filed With SEC on March 29, 2024)
- Amendment No. 3 to Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermgen GmbH, dated May 19, 2020 (English translation) (Filed With SEC on March 29, 2024)
- Combination Study Agreement, dated March 24, 2021, by and among Pieris Pharmaceuticals, Inc. and Seagen Inc (Filed With SEC on May 17, 2021)
- Amendment No. 1 to the February 8, 2018 Platform Agreement by and among Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH and Seattle Genetics, Inc (Filed With SEC on August 10, 2020)
- Letter Agreement by and between the Registrant and Louis A. Matis, M.D., dated as of January 8, 2020 (Filed With SEC on March 13, 2020)
- Description of Registered Securities (Filed With SEC on March 13, 2020)
- Subtenant Recognition and Attornment Agreement, by and among Pieris Pharmaceuticals, Inc., 225 State Street, LLC, and Berenberg Capital Markets LLC, dated as of May 31, 2019 (Filed With SEC on August 9, 2019)
- Open Market Sale Agreement, dated as of August 9, 2019, by and between Pieris Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 9, 2019)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on August 11, 2017)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on August 11, 2017)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on August 11, 2017)
- CONFIDENTIAL TREATMENT REQUESTED EXCLUSIVE OPTION AGREEMENT (Filed With SEC on May 15, 2017)
- EMPLOYMENTAGREEMENT (Filed With SEC on November 13, 2015)
- CONFIDENTIAL TREATMENT REQUESTED RESEARCH AND LICENSING AGREEMENT between (Filed With SEC on March 30, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 30, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 30, 2015)
- SPLIT-OFF AGREEMENT (Filed With SEC on December 18, 2014)
- Agreement by and between (Filed With SEC on December 18, 2014)
- Ruth Oppenheimer, M.A. (Oxford) Offenlich bestelite Übersetzerin für die englische Sprache / Publicly appointed translator for German & English Am Graben le, 86925 Fuchstal,... (Filed With SEC on December 18, 2014)
- Rental account no. 130222 1st upper floor units 1.01 to1.08 (Filed With SEC on December 18, 2014)
- Amendment Agreement between (Filed With SEC on December 18, 2014)
- CONFIDENTIAL TREATMENT REQUESTED RESEARCH AND LICENSING AGREEMENT between (Filed With SEC on December 18, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on December 18, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on December 18, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on December 18, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on December 18, 2014)
- ACQUISITION AGREEMENT (Filed With SEC on December 18, 2014)
